Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $232.90 | Total: $1,164.50 |
| 1 | 10 | $197.28 | Total: $1,972.80 |
| 1 | 25 | $167.14 | Total: $4,178.50 |
| 1 | 50 | $142.48 | Total: $7,124.00 |
| 1 | 100 | $123.30 | Total: $12,330.01 |
Overview
Zelasudil (RXC007) is a Rho-related (ROCK) kinase inhibitor for the study of idiopathic pulmonary fibrosis and inflammation.
Chemical Properties
| Molecular Formula | C22H21F2N7O |
| Molecular Weight | 437.445 |
| CAS Numbers | 2365193-22-0 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O=C(NCC(F)F)C=1C=CC(=CC1)C=2N=C(NC3=CC=C4NN=CC4=C3C5CC5)N(N2)C |
Storage and Handling
0C Short Term, -20C Long Term
References
Lee E, et al. Selective ROCK2 inhibition for treatment of edema and associated conditions World Intellectual Property Organization, WO2022169946. 2022-08-11.